Additional well-known tyrosinase hyperactivity inhibitors include compounds such as hydroquinone (mutagenic, dermatitis, and irritation), arbutin (unstable), L-ascorbic acid (degradation), kojic acid (carcinogenic), and ellagic acid (solubility). Here, TYR is linked to skin disorder.